[1]
Saki, K. et al. 2024. Clinical Trial of Sinudrain Haft Bahr Solution for Symptom Management in Mild to Moderate COVID-19. Archives of Advances in Biosciences. 15, 1 (Dec. 2024), 1–11. DOI:https://doi.org/10.22037/aab.v15i1.47585.